Fundraising Fox

Glenn Short

Investor

Chief Scientific Officer at atai Life Sciences

Boston, Massachusetts, United States

Find your path to Glenn

268 people in our graph share verified history with Glenn β€” schools, employers, funds. One of them is your warm intro.

Trevor KienzleunlockedGlenn: together at University of Virginia (1987)
Γ—5Glenn: together at Massachusetts General Hospital
Γ—4Glenn: together at University of Virginia
Γ—2Glenn: together at Harvard Medical School

About

Glenn Short is Chief Scientific Officer at atai Life Sciences, a role he took in 2025 after serving as Senior Vice President of Early Development from 2022. He leads internal innovation and early-stage product development, integrating translational medicine into development and clinical strategies, and has over 20 years of industry and research experience across venture-backed and public companies. He holds a Ph.D. in Chemistry from the University of Virginia and completed postdoctoral training in molecular biology at Massachusetts General Hospital/Harvard Medical School.

Experience

  1. Viridia Life SciencesBoard Member2022 β€” 2023
  2. Viridia Life SciencesChief Executive Officer2020 β€” 2022
  3. EmpathBioBoard Member2022 β€” 2023
  4. EmpathBioChief Executive Officer2020 β€” 2022
  5. EntheogeniX BiosciencesChief Executive Officer2022 β€” 2023
  6. EntheogeniX BiosciencesChief Scientific Officer2019 β€” 2022
  7. Glenn Short ConsultingSenior Biotech and Pharmaceutical R&D Consultant2019
  8. Axial Biotherapeutics, Inc.VP, Early Development2019
  9. Flex PharmaVP level, Pharmaceutical R&D Consultant2018 β€” 2019
  10. Flex PharmaVP, Research and Translational Development2017 β€” 2018
  11. Flex PharmaVP, Nonclinical and Translational Research2017
  12. Flex PharmaSenior Director, Research2014 β€” 2017
  13. BiotechnologyBiotechnology Consultant2014
  14. Zalicus IncorporatedSenior Director, Research2012 β€” 2013cambridge, ma
  15. Zalicus IncorporatedDirector of Discovery Sciences2009 β€” 2012Cambridge, MA
  16. CombinatoRx, Inc.Team Leader in Discovery Biology2007 β€” 2009Cambridge, MA
  17. CombinatoRx, Inc.Senior Scientist in Platform/Technology Development2005 β€” 2007Cambridge, MA
  18. Massachusetts General HospitalAssociate Biologist2002 β€” 2005
  19. Harvard Medical SchoolHoward Hughes Postdoctoral Scientist in Molecular Biology1999 β€” 2002Department of Molecular Biology, Massachusetts General Hospital

Skills & more

C Level ManagementC-LevelC SuiteLeadership1Molecular Biology15Drug Development17Drug Discovery22Primary PharmacologyMolecular & Cellular Biology2Ion Channel Biology involved in Pain SignalingMolecular Immunology1IND & CTD Preparation
+12 moreMedicinal ChemistryMolecular ModelingHigh Throughput ScreeningMolecular OncologyChemical GenomicsResearch Program ManagementVirtual Program ManagementResearch ProjectsCommunicationGenomicsAssay DevelopmentBiotechnology

From Glenn's professional profile.

Colleagues at atai Life Sciences

Frequently asked questions

Who is Glenn Short?
Glenn Short is Chief Scientific Officer at atai Life Sciences, a role he took in 2025 after serving as Senior Vice President of Early Development from 2022. He leads internal innovation and early-stage product development, integrating translational medicine into development and clinical strategies, and has over 20 years of industry and research experience across venture-backed and public companies. He holds a Ph.D. in Chemistry from the University of Virginia and completed postdoctoral training in molecular biology at Massachusetts General Hospital/Harvard Medical School.
Where does Glenn Short work?
Glenn Short is Chief Scientific Officer at atai Life Sciences.
Where did Glenn Short go to school?
Glenn Short studied at University of Virginia (PhD, Chemistry); University of Virginia (BA, Chemistry).

Same school

Shared employers